Scienture Holdings (SCNX) EBITDA (2013 - 2026)

Scienture Holdings has disclosed EBITDA across 14 years of filings, most recently posting -$2.7 million for Q2 2026.

• In Q2 2026, EBITDA rose 47.66% year-over-year to -$2.7 million; the TTM figure through Jun 2026 stood at -$14.9 million (up 4.96% YoY), while the FY2025 annual figure was -$42.6 million, down 189.71% from the prior year.
• EBITDA came in at -$2.7 million for Q2 2026 at Scienture Holdings, up from -$3.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$218763.0 in Q3 2022 to a low of -$5.5 million in Q1 2024.
• Average EBITDA over 5 years is -$2.3 million, with a median of -$2.0 million recorded in 2022.
• Year-over-year, EBITDA surged 83.12% in 2022 and plunged 581.43% in 2024.
• Over 5 years, EBITDA stood at -$2.6 million in 2022, then dropped by 29.38% to -$3.3 million in 2023, then jumped by 55.03% to -$1.5 million in 2024, then plunged by 244.85% to -$5.2 million in 2025, then soared by 47.66% to -$2.7 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$2.7 million in Q2 2026, -$3.5 million in Q1 2026, and -$5.2 million in Q2 2025.